Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm
A Massachusetts federal judge on Wednesday dismissed a class action lawsuit filed by investors against Biogen and several of its current and former executives over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
